Research Excellence Award
Nnamdi Ikemefuna Okafor – University of the Witwatersrand
Nnamdi Ikemefuna Okafor is a pharmaceutical researcher affiliated with the University of the Witwatersrand, South Africa. His academic work focuses on pharmaceutical development, advanced drug delivery systems, nanomedicine, and pharmaceutical formulation. His research explores innovative approaches to improving therapeutic delivery, drug solubility, formulation performance, and biomedical applications. His scholarly contributions demonstrate engagement with contemporary challenges in pharmaceutical sciences and translational drug development.[1][2]
1. Abstract
Nnamdi Ikemefuna Okafor’s research addresses pharmaceutical formulation, nanotechnology-based therapeutics, and advanced drug delivery. His publications examine liposomal drug delivery, nanoparticle functionalization, microencapsulation, and formulation strategies for improving the pharmaceutical properties of therapeutic compounds. These research directions contribute to ongoing scientific discussions concerning drug bioavailability, targeted delivery, pediatric formulations, and the development of improved therapeutic systems.[3][4]
2. Keywords
Pharmaceutical Development; Drug Delivery Systems; Nanomedicine; Pharmaceutical Formulation; Liposomes; Nanoparticles; Microencapsulation; Pharmaceutical Technology; Targeted Drug Delivery; Biomedical Research.
3. Introduction
Pharmaceutical development integrates formulation science, drug characterization, and innovative delivery technologies to address limitations associated with conventional medicines. Okafor’s scholarly interests align with these objectives through investigations involving nanocarriers, pharmaceutical materials, and therapeutic formulation. His work explores scientific approaches that may improve drug administration and support the development of more effective pharmaceutical products.[3][5]
4. Research Profile
His research profile reflects interdisciplinary engagement across pharmaceutics, pharmaceutical technology, nanomedicine, and drug delivery. His reported institutional affiliation is the University of the Witwatersrand in South Africa. His ORCID record, identified as 0000-0003-3104-9977, provides an additional researcher identification reference for connecting his scholarly activities and publications.[1][2]
5. Research Contributions
His contributions also extend to functionalized polydopamine nanoparticles and their potential applications in therapeutic delivery. Research examining nanoparticle-based approaches for tuberculosis treatment highlights the importance of functionalization, drug delivery efficiency, and innovative nanomaterials. These investigations connect pharmaceutical nanotechnology with infectious disease research and emerging therapeutic strategies.[4]
6. Publications
His publication record includes research on microencapsulation techniques in HIV pediatric formulations, discussing formulation challenges and approaches for improving medicine delivery in children. This work contributes to pharmaceutical research addressing therapeutic accessibility, dosage formulation, and the development of appropriate drug delivery technologies.[5]
7. Research Impact
The supplied Scopus profile information reports 15 documents, 145 citations, and an h-index of 6. These indicators provide quantitative information about his indexed scholarly output and citation activity. His publications demonstrate relevance to pharmaceutical formulation, drug delivery technologies, nanomedicine, and therapeutic development. Continued interdisciplinary research and broader scientific collaboration may further strengthen the visibility and application of his contributions.
8. Award Suitability
Okafor’s research activities demonstrate alignment with the objectives of the Research Excellence Award presented through the International Top Pharmaceutical Awards. His work across advanced drug delivery, nanomedicine, pharmaceutical formulation, and therapeutic development represents relevant contributions to contemporary pharmaceutical sciences. His documented publications and reported research indicators provide a basis for considering his academic contributions within this recognition category.[5]
9. Conclusion
Nnamdi Ikemefuna Okafor demonstrates an active research profile in pharmaceutical development and advanced drug delivery. His publications address relevant challenges in nanomedicine, liposomal formulations, and therapeutic delivery systems. These contributions provide a foundation for continued research in pharmaceutical innovation and support his consideration for the Research Excellence Award under the International Top Pharmaceutical Awards.
10. External Links
11. References
- Elsevier. (n.d.). Scopus author details: Nnamdi Ikemefuna Okafor, Author ID 57211213082. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57211213082
- Okafor, N. I., & Nnaji, N. J. (2025). The Preparation of Abacavir-Loaded Liposomes for Improved Drug Solubility and Dissolution Rate. Pharmaceutical Chemistry Journal, 59(2), 241–257.
DOI: https://doi.org/10.1007/s11094-025-03385-1
- Okafor, N. I., Nnaji, P., Nnolum-Orji, N. F., & Choonara, Y. E. (2025). Functionalized Polydopamine Nanoparticles: A Promising Drug Delivery Platform for the Treatment of Tuberculosis. Drug Development Research.
DOI: https://doi.org/10.1002/ddr.70109
- Okafor, N. I., & Mudigonda, K. (2024). Microencapsulation Techniques in HIV Pediatric Formulations: Advances and Future Outlook. Advances in Pharmacological and Pharmaceutical Sciences, 2024, 5081655.
DOI: https://doi.org/10.1155/2024/5081655
- Okafor, N. I., & Nnaji, N. J. (2024). Liposomes, Facilitating the Encapsulation and Improved Solubility of Zidovudine Antiretroviral Drug. BioNanoScience, 14, 4877–4894.
DOI: https://doi.org/10.1007/s12668-024-01504-y